As lawmakers consider bills to regulate the nation's compounding pharmacies, trade groups and pharmaceutical companies — including KV Pharmaceutical — are ramping up their spending on lobbyists in preparation for the battle ahead.
Bills have been introduced in both the House and Senate proposing that the FDA be given oversight of pharmacy compounding, and in the past two months, at least 10 reports have been filed in the Senate's database of lobbyists that name pharmacy compounding as an area of interest, Politico reports.
The International Academy of Compounding Pharmacists historically has spent an average of $20,000 per quarter on lobbying, but in the first six months of this year, it has spent $440,000 on lobbying.
On the other side of the issue, pharmaceutical organizations such as KV, Auxilium and the Generic Pharmaceutical Association (GPhA) also are staffing up on lobbyists, with the GPhA spending more than $1 million already this year.
continue to read here
No comments:
Post a Comment